iScience (Jun 2021)

Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain

  • Chao Wu,
  • Abraham J. Qavi,
  • Asmaa Hachim,
  • Niloufar Kavian,
  • Aidan R. Cole,
  • Austin B. Moyle,
  • Nicole D. Wagner,
  • Joyce Sweeney-Gibbons,
  • Henry W. Rohrs,
  • Michael L. Gross,
  • J. S. Malik Peiris,
  • Christopher F. Basler,
  • Christopher W. Farnsworth,
  • Sophie A. Valkenburg,
  • Gaya K. Amarasinghe,
  • Daisy W. Leung

Journal volume & issue
Vol. 24, no. 6
p. 102681

Abstract

Read online

Summary: Nucleocapsid (N) encoded by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) plays key roles in the replication cycle and is a critical serological marker. Here, we characterize essential biochemical properties of N and describe the utility of these insights in serological studies. We define N domains important for oligomerization and RNA binding and show that N oligomerization provides a high-affinity RNA-binding platform. We also map the RNA-binding interface, showing protection in the N-terminal domain and linker region. In addition, phosphorylation causes reduction of RNA binding and redistribution of N from liquid droplets to loose coils, showing how N-RNA accessibility and assembly may be regulated by phosphorylation. Finally, we find that the C-terminal domain of N is the most immunogenic, based on antibody binding to patient samples. Together, we provide a biochemical description of SARS-CoV-2 N and highlight the value of using N domains as highly specific and sensitive diagnostic markers.

Keywords